631 related articles for article (PubMed ID: 28483418)
41. An Mll4/COMPASS-Lsd1 epigenetic axis governs enhancer function and pluripotency transition in embryonic stem cells.
Cao K; Collings CK; Morgan MA; Marshall SA; Rendleman EJ; Ozark PA; Smith ER; Shilatifard A
Sci Adv; 2018 Jan; 4(1):eaap8747. PubMed ID: 29404406
[TBL] [Abstract][Full Text] [Related]
42. Brd4 binds to active enhancers to control cell identity gene induction in adipogenesis and myogenesis.
Lee JE; Park YK; Park S; Jang Y; Waring N; Dey A; Ozato K; Lai B; Peng W; Ge K
Nat Commun; 2017 Dec; 8(1):2217. PubMed ID: 29263365
[TBL] [Abstract][Full Text] [Related]
43. Widespread transcriptional pausing and elongation control at enhancers.
Henriques T; Scruggs BS; Inouye MO; Muse GW; Williams LH; Burkholder AB; Lavender CA; Fargo DC; Adelman K
Genes Dev; 2018 Jan; 32(1):26-41. PubMed ID: 29378787
[TBL] [Abstract][Full Text] [Related]
44. DNA methylation analysis of multiple imprinted DMRs in Sotos syndrome reveals IGF2-DMR0 as a DNA methylation-dependent, P0 promoter-specific enhancer.
Watanabe H; Higashimoto K; Miyake N; Morita S; Horii T; Kimura M; Suzuki T; Maeda T; Hidaka H; Aoki S; Yatsuki H; Okamoto N; Uemura T; Hatada I; Matsumoto N; Soejima H
FASEB J; 2020 Jan; 34(1):960-973. PubMed ID: 31914674
[TBL] [Abstract][Full Text] [Related]
45. Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis.
Ananthanarayanan M; Li Y; Surapureddi S; Balasubramaniyan N; Ahn J; Goldstein JA; Suchy FJ
Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G771-81. PubMed ID: 21330447
[TBL] [Abstract][Full Text] [Related]
46. Restoration of KMT2C/MLL3 in human colorectal cancer cells reinforces genome-wide H3K4me1 profiles and influences cell growth and gene expression.
Larsson C; Cordeddu L; Siggens L; Pandzic T; Kundu S; He L; Ali MA; Pristovšek N; Hartman K; Ekwall K; Sjöblom T
Clin Epigenetics; 2020 May; 12(1):74. PubMed ID: 32471474
[TBL] [Abstract][Full Text] [Related]
47. MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity.
Zheng JY; Wang CY; Gao C; Xiao Q; Huang CW; Wu M; Li LY
Cell Death Dis; 2021 Apr; 12(4):364. PubMed ID: 33824309
[TBL] [Abstract][Full Text] [Related]
48. Structural basis of nucleosome recognition and modification by MLL methyltransferases.
Xue H; Yao T; Cao M; Zhu G; Li Y; Yuan G; Chen Y; Lei M; Huang J
Nature; 2019 Sep; 573(7774):445-449. PubMed ID: 31485071
[TBL] [Abstract][Full Text] [Related]
49. Genomic Location of PRMT6-Dependent H3R2 Methylation Is Linked to the Transcriptional Outcome of Associated Genes.
Bouchard C; Sahu P; Meixner M; Nötzold RR; Rust MB; Kremmer E; Feederle R; Hart-Smith G; Finkernagel F; Bartkuhn M; Savai Pullamsetti S; Nist A; Stiewe T; Philipsen S; Bauer UM
Cell Rep; 2018 Sep; 24(12):3339-3352. PubMed ID: 30232013
[TBL] [Abstract][Full Text] [Related]
50. Enhancer decommissioning by MLL4 ablation elicits dsRNA-interferon signaling and GSDMD-mediated pyroptosis to potentiate anti-tumor immunity.
Ning H; Huang S; Lei Y; Zhi R; Yan H; Jin J; Hu Z; Guo K; Liu J; Yang J; Liu Z; Ba Y; Gao X; Hu D
Nat Commun; 2022 Nov; 13(1):6578. PubMed ID: 36323669
[TBL] [Abstract][Full Text] [Related]
51. The Drosophila ortholog of MLL3 and MLL4, trithorax related, functions as a negative regulator of tissue growth.
Kanda H; Nguyen A; Chen L; Okano H; Hariharan IK
Mol Cell Biol; 2013 May; 33(9):1702-10. PubMed ID: 23459941
[TBL] [Abstract][Full Text] [Related]
52. Circadian clock function does not require the histone methyltransferase MLL3.
Baxter M; Poolman T; Cunningham P; Hunter L; Voronkov M; Kitchen GB; Goosey L; Begley N; Kay D; Hespe A; Maidstone R; Loudon ASI; Ray DW
FASEB J; 2022 Jul; 36(7):e22356. PubMed ID: 35704036
[TBL] [Abstract][Full Text] [Related]
53. ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.
Kim DH; Lee J; Lee B; Lee JW
Mol Endocrinol; 2009 Oct; 23(10):1556-62. PubMed ID: 19556342
[TBL] [Abstract][Full Text] [Related]
54. A unique chromatin signature uncovers early developmental enhancers in humans.
Rada-Iglesias A; Bajpai R; Swigut T; Brugmann SA; Flynn RA; Wysocka J
Nature; 2011 Feb; 470(7333):279-83. PubMed ID: 21160473
[TBL] [Abstract][Full Text] [Related]
55. BACH1 recruits NANOG and histone H3 lysine 4 methyltransferase MLL/SET1 complexes to regulate enhancer-promoter activity and maintains pluripotency.
Niu C; Wang S; Guo J; Wei X; Jia M; Chen Z; Gong W; Qin Y; Wang X; Zhi X; Lu M; Chen S; Gu M; Zhang J; Han JJ; Lan F; Meng D
Nucleic Acids Res; 2021 Feb; 49(4):1972-1986. PubMed ID: 33503260
[TBL] [Abstract][Full Text] [Related]
56. MLL3/MLL4/COMPASS Family on Epigenetic Regulation of Enhancer Function and Cancer.
Sze CC; Shilatifard A
Cold Spring Harb Perspect Med; 2016 Nov; 6(11):. PubMed ID: 27638352
[TBL] [Abstract][Full Text] [Related]
57. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
Kang Z; Jänne OA; Palvimo JJ
Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
[TBL] [Abstract][Full Text] [Related]
58. Pax6 associates with H3K4-specific histone methyltransferases Mll1, Mll2, and Set1a and regulates H3K4 methylation at promoters and enhancers.
Sun J; Zhao Y; McGreal R; Cohen-Tayar Y; Rockowitz S; Wilczek C; Ashery-Padan R; Shechter D; Zheng D; Cvekl A
Epigenetics Chromatin; 2016; 9(1):37. PubMed ID: 27617035
[TBL] [Abstract][Full Text] [Related]
59. Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant.
Denissov S; Hofemeister H; Marks H; Kranz A; Ciotta G; Singh S; Anastassiadis K; Stunnenberg HG; Stewart AF
Development; 2014 Feb; 141(3):526-37. PubMed ID: 24423662
[TBL] [Abstract][Full Text] [Related]
60. DNA methylation regulates discrimination of enhancers from promoters through a H3K4me1-H3K4me3 seesaw mechanism.
Sharifi-Zarchi A; Gerovska D; Adachi K; Totonchi M; Pezeshk H; Taft RJ; Schöler HR; Chitsaz H; Sadeghi M; Baharvand H; Araúzo-Bravo MJ
BMC Genomics; 2017 Dec; 18(1):964. PubMed ID: 29233090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
